Embed Size (px)
Citation preview
Don’t forget the 7th Bordeaux PharmacoEpi Festival, expected on May 22-24, 2018
Over three days, six world-class experts will come to Bordeaux to talk of the topic of their choice.
Good Science, good Wine, good Fun!
More information soon on http://pharmacoepi.bordeaux-festival.eu/
• Permanent team of > 40 staff • Transparency and Quality
- Respect of the ENCePP code of conduct - Quality Management System based on ISO 9001 principles
• > 30 field studies: 50 to 46 000 patients • > 50 studies using national health insurance
system databases • > 100 publications for the past 5 years
Bordeaux PharmacoEpi
Research Platform in Pharmacoepidemiology
At the 33rd ICPE, Montréal
Bordeaux PharmacoEpi (BPE)
Plateforme de recherche en Pharmaco-épidémiologie
Service de Pharmacologie médicale, CIC Bordeaux CIC1401 INSERM - Université de BORDEAUX - CHU de Bordeaux - Adera
Bâtiment Le Tondu - case 41 - 146 rue Léo Saignat - 33076 Bordeaux Cedex – France ( +33 (0)5 57 57 46 75 - http://www.pharmacoepi.eu - [email protected]
Pharmacologie médicale
Bordeaux PharmacoEpi CIC Bordeaux CIC1401
Posters (XXX/XX) : Publication Number / Poster Number
Tuesday, August 29, 2017 Room 220BC
(565/112) Drug usage patterns of Pylera in France using the national claims database. P. Blin, M. Rouyer, E. Guiard, F. Zerbib, B. Diquet, F. Mégraud, F. Tison, A. Abouelfath, R. Lassalle, C. Droz-Perroteau, N. Moore
(599/146) Effectiveness of ranibizumab intravitreal injections in visual impairment due to macular edema secondary to retinal vein occlusion from the French BOREAL cohorts. P. Blin, C. Delcourt, A. Glacet-Bernard, L. Finzi, R. Lassalle, A. Chartier, MA. Bernard, P. Diez, C. Droz-Perroteau, A. Grolleau, A. Grelaud, N. Moore
(600/147) Effectiveness of ranibizumab intravitreal injections in visual impairment due to diabetic macular edema from the French BOREAL cohort. P. Blin, C. Delcourt, P. Massin, PJ. Guillausseau, L. Finzi, R. Lassalle, A. Chartier, MA. Bernard, F. Hamoud, C. Droz-Perroteau, A. Grolleau, A. Grelaud, N. Moore
(604/151) Outcomes In post-myocardial infarction patients similar to those of the PEGASUS-TIMI-54 trial: A cohort study in the French national claims database sample EGB. N. Moore, Patrick Blin, C. Dureau-Pournin, R. Lassalle, J. Jové, F. Thomas-Delecourt, N. Danchin, C. Droz-Perroteau
(632/179) Alert generation using the case-population approach in the French claims databases (ALCAPONE). N. Thurin, R. Lassalle, P. Blin, M. Pénichon, M. Schuemie, J.J. Gagne, J. Rassen, J. Benichou, A. Weill, C. Droz-Perroteau, N. Moore
(651/198) Drug-induced acute liver injury (ALI) in the French claims database: description of cases. A. Grolleau, V. Barbet, N. Thurin, R. Lassalle, M. Duong, C. Droz-Perroteau, N. Moore
(652/199) Drug-induced acute liver injury (ALI) in the French claims database: individual and population risks. A. Grolleau, V. Barbet, N. Thurin, R. Lassalle, M. Duong, C. Droz-Perroteau, N. Moore
(656/203) A safety and pharmacokinetic study in real-life practice of Pylera in France: the SAPHARY study. P. Blin, B. Lelièvre, M. Rouyer, F. Zerbib, B. Diquet, F. Mégraud, F. Tison, E. Guiard, E. Bignon, V. Barbet, R. Lassalle, C. Droz-Perroteau, N. Moore Wednesday, August 30, 2017 Room 220BC
(891/53) Long-term outcomes after myocardial infarction: a cohort study in the French national claims database. N. Moore, P. Blin, C. Dureau-Pournin, R. Lassalle, J. Jové, F. Thomas-Delecourt, N Danchin, C. Droz-Perroteau
(923/85) The French National Health Insurance Claims Databases In France, SNIIRAM and EGB: A Whole-Country 66 million Persons Resource For PharmacoEpidemiology. N. Moore, P. Blin, M. Duong, J. Bezin, A. Pariente, R. Lassalle, C. Droz-Perroteau.
(954/116) Oralair® real-word treatment pattern from a French cohort study. P. Blin, P. Demoly, M. Drouet, S. Lignot-Maleyran, H. Maizi, S. Lorrain, R. Lassalle, C. Droz-Perroteau, N. Moore, M. Molimard
Oral Presentations (XXX) Publication Number
Monday, August 28, 2017 Room 524AD (Cardio) Vascular Safety of OTC 5:00pm - 6:30pm
6:00pm (75) Cardiovascular safety of OTC strength ibuprofen and paracetamol in a representative sample of the French national healthcare system database. Speaker: Pr Nicholas Moore Wednesday, August 30, 2017 Room 520AD Better, Worse, or the Same? 8:30am - 10:00am
8:30am (728) Effectiveness and safety of ticagrelor compared to clopidogrel and prasugrel: results from a cohort study in the nationwide French claims and hospitalisation database (SNIIRAM). Speaker: Régis Lassalle 9:45am (733) Effectiveness and safety of direct oral anticoagulants versus VKA: a cohort study of about 100,000 non-valvular atrial fibrillation from the nationwide French claims and hospitalisation database. Speaker: Dr Patrick Blin
Posters and Oral presentation also downloadable on http://sibylle.pharmaco.u-bordeaux2.fr/congres/icpe_2017_BPE/
Meet our Team Members at the 33rd ICPE
Nicholas MOORE, Chief Executive Officer Patrick BLIN, Chief Scientific Officer Cécile DROZ-PERROTEAU, Chief Operating Officer Nicolas THURIN, Scientific Advisor Régis LASSALLE, Chief of Biostatistics & and Data Management Angela GRELAUD-BOUSSINOT, Project Leader
